Details
Stereochemistry | ACHIRAL |
Molecular Formula | C9H15N3O.2ClH |
Molecular Weight | 254.157 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.CCN1CCC2=C(CC1)N=C(N)O2
InChI
InChIKey=HBLPYIOKPJVFQW-UHFFFAOYSA-N
InChI=1S/C9H15N3O.2ClH/c1-2-12-5-3-7-8(4-6-12)13-9(10)11-7;;/h2-6H2,1H3,(H2,10,11);2*1H
Azepexole (or previously known as B-HT 933), a selective alpha 2-adrenoceptor agonist that was studied for the man with physiological tremor. It was shown that the drug produced sedation compared to placebo but not when compared to pre-treatment values. Some studies also have revealed the anti-tussive and antihypertensive properties of azepexole.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2866788
azepexole 10 mg
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
36067-72-8
Created by
admin on Fri Dec 15 15:13:23 GMT 2023 , Edited by admin on Fri Dec 15 15:13:23 GMT 2023
|
PRIMARY | |||
|
169743
Created by
admin on Fri Dec 15 15:13:23 GMT 2023 , Edited by admin on Fri Dec 15 15:13:23 GMT 2023
|
PRIMARY | |||
|
310831
Created by
admin on Fri Dec 15 15:13:23 GMT 2023 , Edited by admin on Fri Dec 15 15:13:23 GMT 2023
|
PRIMARY | |||
|
O596V52O42
Created by
admin on Fri Dec 15 15:13:23 GMT 2023 , Edited by admin on Fri Dec 15 15:13:23 GMT 2023
|
PRIMARY | |||
|
DTXSID5045756
Created by
admin on Fri Dec 15 15:13:23 GMT 2023 , Edited by admin on Fri Dec 15 15:13:23 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD